The Medicines Company today announced that the United States Patent and Trademark Office (PTO) issued a new U.S. patent No. 7,582,727 ('727 patent). The '727 patent relates to a more consistent and improved Angiomax drug product.
The details can be read here.
No comments:
Post a Comment